ConductScience.org, home

Trial · NCT07896876

Selenium, Sarcopenia, and Frailty in Hemodialysis

NCT07896876, Completed, Ankara City Hospital Bilkent

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Selenium, Sarcopenia, and Frailty in Hemodialysis. Trials, record NCT07896876. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896876

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Selenium, Sarcopenia, and Frailty in Hemodialysis
NCT number
NCT07896876
Status
Completed
Enrollment
78 participants, actual
Lead sponsor
Ankara City Hospital Bilkent
Conditions
Frailty, Sarcopenia, Selenium
Interventions
FRAIL scale, sarc-f, time up go test, hand grip strength
First posted
2026-10-27
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primaryfrailty20 weeks
FRAIL scale: The FRAIL scale consists of 5 items, each scored on a scale of 0-1. The total score ranges from 0 to 5. Based on the total score, 0 is classified as robust/non-frail, 1-2 as prefrail, and 3 as frail.
Primarysarcopenia sarc-f20 weeks
This is a questionnaire used for sarcopenia screening, which has been validated and tested for reliability in Turkish. Its components are defined as follows: Strength (S), Assistance with walking (A), Rising from a chair (R), Climbing stairs (C), and Falls (F). The questionnaire consists of 5 questions, each scored on a scale of 0-2 points. The recommended cut-off value for this scale is ≥4 points. A score of 4 or higher indicates a risk for sarcopenia.
Primarytime up go test20 weeks
Physical Performance: The "Timed Up and Go" (TUG) test was administered to assess the functional performance of the participants. The TUG test is a practical and rapidly applied assessment that measures walking speed, functional mobility, and dynamic balance. For the test, individuals were asked to sit on an armless chair with their feet touching the floor; upon the command "go," they were instructed to stand up, walk along a marked 3-meter path, turn around, and return to sit back down in the chair. During this process, the time taken by each individual to complete the activity was recorded.
Primaryhand grip strength20 weeksHandgrip strength (HGS) was measured using a hydraulic hand dynamometer (Baseline). Measurements were performed three times on the hand without a fistula, and the highest value was recorded.
Primaryselenium20 weeks
Serum selenium concentrations were measured using inductively coupled plasma-mass spectrometry (ICP-MS) with an Agilent 7500 ICP-MS instrument (Agilent Technologies, USA), in accordance with the laboratory's analytical procedure (code: TIP-TÇT-52). Results were recorded in micrograms per liter (µg/L). Based on a previous study, a serum selenium level of \<70 µg/L was defined as selenium deficiency in our study.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
11253156BACKGROUNDPubMed
21372251BACKGROUNDPubMed
25287433RESULTPubMed
29644065BACKGROUNDPubMed
29673501BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07896876

GET https://conductscience.org/api/trials/v1/NCT07896876/registered